Skip to main content

Advertisement

Table 1 Patient Description

From: Gel-type autologous chondrocyte (Chondron™) implantation for treatment of articular cartilage defects of the knee

Gender Male n (%) 54 (55.1%)
  Female n (%) 44 (44.9%)
Age (years) Mean ± std (Min ~ Max) 43.72 ± 9.10 (17 ~ 65)
  <30 years n (%) 10 (10.2%)
  30~39 years n (%) 12 (12.2%)
  40~49 years n (%) 53 (54.1%)
  > = 50 years n (%) 23 (23.5%)
Defect location Femoral condyle n (%) 83 (84.7%)
  Other n (%) 15 (15.3%)
Defect Size (cm2) Mean ± std (Min ~ Max) 5.23 ± 2.70 (1.00 ~ 14.50)
  < 4.0 cm2 n (%) 29 (29.6%)
  4.0~7.9 cm2 n (%) 57 (58.2%)
  >8.0 cm2 n (%) 12 (12.2%)
F/u period (Months) Mean ± std (Min ~ Max) 24.35 ± 8.35 (12~ 52)
  13~24 Months n (%) 58 (59.2%)
  25 Months~ n (%) 40 (40.8%)